Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norman L Block

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
World Journal of Gastroenterology|May 31, 2014
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesFlorian Hohla, Thomas Winder, Richard Greil, et al.
The Prostate|January 3, 2013
Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
Anti-Cancer Drugs|August 29, 2012
Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-IIKaroly Szepeshazi, Andrew V Schally, Ferenc G Rick, et al.
Vitamins and Hormones|February 25, 2014
Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitusBarbara Ludwig, Andreas Barthel, Andreas Reichel, et al.
Oncotarget|March 23, 2013
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormoneMiklos Jaszberenyi, Andrew V Schally, Norman L Block, et al.
Current Opinion in Urology|December 4, 2012
Hormonal manipulation of benign prostatic hyperplasiaFerenc G Rick, Seyed H Saadat, Luca Szalontay, et al.
Aging|December 6, 2012
Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's diseaseMiklos Jaszberenyi, Ferenc G Rick, Luca Szalontay, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH)Stefan Buchholz, Stephan Seitz, Jörg B Engel, et al.
Neuroendocrinology|March 2, 2012
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissueLuca Szalontay, Ronald J Benveniste, Andrew V Schally, et al.
The Prostate|October 15, 2010
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
World Journal of Gastroenterology|May 31, 2014
Targeted therapy in advanced metastatic colorectal cancer: current concepts and perspectivesFlorian Hohla, Thomas Winder, Richard Greil, et al.
The Prostate|January 3, 2013
Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
Anti-Cancer Drugs|August 29, 2012
Powerful inhibition of in-vivo growth of experimental hepatic cancers by bombesin/gastrin-releasing peptide antagonist RC-3940-IIKaroly Szepeshazi, Andrew V Schally, Ferenc G Rick, et al.
Vitamins and Hormones|February 25, 2014
Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitusBarbara Ludwig, Andreas Barthel, Andreas Reichel, et al.
Oncotarget|March 23, 2013
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormoneMiklos Jaszberenyi, Andrew V Schally, Norman L Block, et al.
Current Opinion in Urology|December 4, 2012
Hormonal manipulation of benign prostatic hyperplasiaFerenc G Rick, Seyed H Saadat, Luca Szalontay, et al.
Aging|December 6, 2012
Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's diseaseMiklos Jaszberenyi, Ferenc G Rick, Luca Szalontay, et al.
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH)Stefan Buchholz, Stephan Seitz, Jörg B Engel, et al.
Neuroendocrinology|March 2, 2012
Inhibitory effects of GHRH antagonists on human GH-secreting adenoma tissueLuca Szalontay, Ronald J Benveniste, Andrew V Schally, et al.
The Prostate|October 15, 2010
LHRH antagonist Cetrorelix reduces prostate size and gene expression of proinflammatory cytokines and growth factors in a rat model of benign prostatic hyperplasiaFerenc G Rick, Andrew V Schally, Norman L Block, et al.
Pageof 9